114 related articles for article (PubMed ID: 9682641)
1. Variation in the staging of colorectal carcinomas: a survey of current practice.
Raraty MG; Winstanley JH
Ann R Coll Surg Engl; 1998 May; 80(3):188-91. PubMed ID: 9682641
[TBL] [Abstract][Full Text] [Related]
2. Surgical trainees' understanding of Dukes' staging in rectal cancer.
Rahman GA; Mungadi IA
Niger J Med; 2009; 18(1):75-8. PubMed ID: 19485154
[TBL] [Abstract][Full Text] [Related]
3. Dukes' staging is poorly understood by doctors managing colorectal cancer.
Mainprize KS; Mortensen NJ; Warren BF
Ann R Coll Surg Engl; 2002 Jan; 84(1):23-5. PubMed ID: 11892729
[TBL] [Abstract][Full Text] [Related]
4. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
5. Variance of surgeons versus pathologists in staging of colorectal cancer.
Jha MK; Corbett WA; Wilson RG; Koreli A; Papagrigoriadis S
Minerva Chir; 2006 Oct; 61(5):385-91. PubMed ID: 17159746
[TBL] [Abstract][Full Text] [Related]
6. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
7. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
9. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
10. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
[TBL] [Abstract][Full Text] [Related]
11. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
12. [Classification of colorectal cancers: current results from the catchment area of the Graz Institute of Pathology].
Klimpfinger M; Hauser H; Beham A; Denk H
Wien Med Wochenschr; 1988 Jun; 138(11-12):267-70. PubMed ID: 3176506
[TBL] [Abstract][Full Text] [Related]
13. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
[TBL] [Abstract][Full Text] [Related]
14. Barriers to optimal assessment of lymph nodes in colorectal cancer specimens.
Wright FC; Law CH; Last LD; Ritacco R; Kumar D; Hsieh E; Khalifa M; Smith AJ
Am J Clin Pathol; 2004 May; 121(5):663-70. PubMed ID: 15151206
[TBL] [Abstract][Full Text] [Related]
15. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
16. Molecular staging for survival prediction of colorectal cancer patients.
Eschrich S; Yang I; Bloom G; Kwong KY; Boulware D; Cantor A; Coppola D; Kruhøffer M; Aaltonen L; Orntoft TF; Quackenbush J; Yeatman TJ
J Clin Oncol; 2005 May; 23(15):3526-35. PubMed ID: 15908663
[TBL] [Abstract][Full Text] [Related]
17. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
19. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
Fan YZ; Li XP; Liu WF; Li GM
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
[TBL] [Abstract][Full Text] [Related]
20. The surgeon's decision as a prognostic factor in a pool of patients with colorectal cancer coming from different institutions.
Franchi F; Rossi L; Izzo L; Binda B; Pastore C; Falconi C; Amoroso A; Cammarata A; Cicconetti F; Seminara P
J Exp Clin Cancer Res; 2003 Sep; 22(3):385-8. PubMed ID: 14582695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
